SCHEMBL9525580

SCHEMBL9525580

CC(C)(C)OC(=O)NC[CH]c1ccc2ccccc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4A O75164 1/20 0.48
ACACB O00763 1/20 0.47
CTSB P07858 1/20 0.45
CTSS P25774 1/20 0.45
CTSK P43235 1/20 0.45
NQO2 P16083 1/20 0.44
CNR2 P34972 2/20 0.42
GABRB1 P18505 1/20 0.42
GABRB2 P47870 1/20 0.42
PPARA Q07869 1/20 0.42
MAPT P10636 3/20 0.41
APP P05067 1/20 0.41
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 1/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
HIF1A Q16665 1/20 0.40
BCHE P06276 1/20 0.39
HDAC1 Q13547 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7453149 0.83 NFKB1 (0.46) KDM4ACTSBCTSSCTSKMAPT
SCHEMBL9530194 0.76 NQO2 (0.47) KDM4ACTSSCTSKNQO2MAPT
SCHEMBL13903530 0.76 KDM4E (0.64) MAPTKDM4EALDH1A1NPC1RAB9A
SCHEMBL29679010 0.74 KDM4A (0.50) KDM4AACACBCTSSCTSKNQO2
SCHEMBL28074205 0.74 ACE (0.40) CTSBCTSSCTSKNQO2
SCHEMBL27820408 0.73 HDAC3 (0.45) PPARAMAPTKDM4EALDH1A1GAA
SCHEMBL23843620 0.73 PDK2 (0.60) KDM4AACACBNQO2CNR2KDM4E
SCHEMBL30301420 0.73 HDAC3 (0.54) KDM4ANQO2GABRB1GABRB2HDAC1
SCHEMBL27015167 0.73 HDAC3 (0.54) KDM4ANQO2GABRB1GABRB2HDAC1
SCHEMBL10431398 0.72 CTSS (0.43) KDM4ACTSSCTSKPPARAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0365045-B1 Perhydrothiazepine derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1993-12-01 EP disclosed
EP-0365045-A1 Perhydrothiazepine derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1990-04-25 EP disclosed